INmune Bio, Inc. (INMB) Tops Q1 EPS by 6c

INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.43), $0.06 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $50 thousand.

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Tesla (TSLA) call put ratio 1.1 calls to 1 put on 3.3M options
• Increasing unusual option volume: UTHR DOMO IHI XIFR ALKS AM CTSH GDS DFTX